Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance
Abstract Expression of the chromatin-associated protein HMGA2 correlates with progression, metastasis and therapy resistance in pancreatic ductal adenocarcinoma (PDAC). Hmga2 has also been identified as a marker of a transient subpopulation of PDAC cells that has increased metastatic ability. Here,...
Guardado en:
Autores principales: | Shin-Heng Chiou, Madeleine Dorsch, Eva Kusch, Santiago Naranjo, Margaret M. Kozak, Albert C. Koong, Monte M. Winslow, Barbara M. Grüner |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b72834b1a36a49d0bfd2fb6d72fac298 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
High expression of WNT7A predicts poor prognosis and promote tumor metastasis in pancreatic ductal adenocarcinoma
por: Dong-jin Wu, et al.
Publicado: (2018) -
Targeting Tumor-Stromal Interactions in Pancreatic Cancer: Impact of Collagens and Mechanical Traits
por: Parniyan Maneshi, et al.
Publicado: (2021) -
Cell Lineage Infidelity in PDAC Progression and Therapy Resistance
por: Antonia Malinova, et al.
Publicado: (2021) -
Identification and functional analysis of novel oncogene DDX60L in pancreatic ductal adenocarcinoma
por: Hongjin Wu, et al.
Publicado: (2021) -
CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma
por: Cai,Yi, et al.
Publicado: (2018)